Results 161 to 170 of about 1,990 (201)

Genomewide association study of a homogeneous multiple sclerosis cohort: Tumefactive demyelination. [PDF]

Mult Scler
Zhao-Fleming HH, Decker PA, Kosel ML, Drucker KL, Kollmeyer T, Lachance DH, Clarkson BD, Howe CL, Jenkins R, Tobin WO, Eckel-Passow J.   +10 more
europepmc   +1 more source

A misdiagnosed case of tumefactive demyelinating lesion mimicking glioma: Imaging pitfalls and diagnostic lessons. [PDF]

Radiol Case Rep
Li CC, Wang GL, You XP, Wei WJ, Pan F, Deng ZJ, Shen GH, Tan XP.   +7 more
europepmc   +1 more source

Deep Learning MRI Models for the Differential Diagnosis of Tumefactive Demyelination versus <i>IDH</i> Wild-Type Glioblastoma. [PDF]

AJNR Am J Neuroradiol
Conte GM, Moassefi M, Decker PA, Kosel ML, McCarthy CB, Sagen JA, Nikanpour Y, Fereidan-Esfahani M, Ruff MW, Guido FS, Pump HK, Burns TC, Jenkins RB, Erickson BJ, Lachance DH, Tobin WO, Eckel-Passow JE.   +16 more
europepmc   +1 more source

Demystifying a Demyelinating Disease: A Case Report of Tumefactive Multiple Sclerosis [PDF]

Jandali, Ramzy, Shih, Evan
core  

Some of the next articles are maybe not open access.

Related searches:

Cyclophosphamide in treatment of tumefactive multiple sclerosis

Multiple Sclerosis and Related Disorders, 2021
. To review the Mayo clinic experience of cyclophosphamide in the treatment of tumefactive Multiple Sclerosis (TMS).. Retrospective chart review was performed to identify patients with TMS who did not respond to corticosteroid and plasma exchange and were treated with cyclophosphamide.
Mahboobeh Fereidan-Esfahani, W. Oliver Tobin   +1 more
openaire   +4 more sources

Relapsing-remitting tumefactive multiple sclerosis

Multiple Sclerosis Journal, 2005
Tumefactive multiple sclerosis (MS) is a rare form of demyelinating disease. The natural course of the disease has been characterized as presenting with a mass-like demyelinating lesion converting to typical relapsing-remitting disease with future exacerbations.
Stephen M, Selkirk, Jiong, Shi
openaire   +2 more sources

Late-onset tumefactive multiple sclerosis

Radiation Medicine, 2008
A patient with tumefactive multiple sclerosis (MS) initially presented at the age of 87 years; the revised diagnostic criteria from the International Panel on MS (2001) were fulfilled. Late-onset MS and tumefactive demyelinating lesions are discussed. This case suggests that MS can occur at any age. MS should be borne in mind for differential diagnosis
Taizo, Takeuchi, Mitsuhiro, Ogura, Morio, Sato, Nobuyuki, Kawai, Hirohiko, Tanihata, Isao, Takasaka, Hiroki, Minamiguchi, Motoki, Nakai, Toru, Itakura   +8 more
openaire   +2 more sources

Focal Hyperhidrosis in Tumefactive Multiple Sclerosis

Archives of Neurology, 2010
No abstract ...
Iorio, Raffaele, Plantone, Domenico, Frisullo, Giovanni, Nociti, Viviana, Patanella, Agata Katia, Tonali, Pietro Attilio, Colosimo, Cesare, Batocchi, Anna Paola   +7 more
openaire   +4 more sources

Bilateral Tumefactive Multiple Sclerosis Lesions

Rivista di Neuroradiologia, 2005
Tumefactive lesions are a rare form of multiple sclerosis (MS) presentation often provoking a diagnostic dilemma with brain tumour or abscess. We describe two cases of tumefactive demyelinating MS plaques and two different approaches. In the first patient the clinical and laboratory findings were consistent with MS, a diagnosis supported by the rapid ...
A. Haritanti, A. Lefkopoulos, E. Papadopoulou, C. Kouskouras, N. Hatzisavvas, M. Pashalidou, N. Taskos, A. Dimitriadis   +7 more
openaire   +1 more source